KCI Holdings, an LBO'd provider of advanced wound care systems and tissue implants, filed on Thursday with the SEC to raise up to $500 million in an initial public offering.
The San Antonio , TX-based company was founded in 1976 and booked $1.5 billion in sales for the 12 months ended December 31, 2018. It plans to list on the NYSE under the symbol KCIH.RC. KCI Holdings filed confidentially on February 14, 2019. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch are the joint bookrunners on the deal. No pricing terms were disclosed.
The article LBO'd medical technology company KCI Holdings files for an estimated $500 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
